Hemo Organic

Hemo Organic P/B

The P/B (Price-to-Book Ratio) of Hemo Organic (524590.BO) as of Nov 2, 2026 is -51.66. In the previous year, P/B (Price-to-Book Ratio) was -24.82 — a change of 108.18% (lower).

P/B

-51.66

YoY

108.18%

Last updated:

P/B (Price-to-Book Ratio) of Hemo Organic is 2025 -51.66 . P/B (Price-to-Book Ratio) of Hemo Organic was 2024 -24.82 . It decreases by 108.18% lower compared to the previous year.

The Hemo Organic P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2014
5.29 INR
Jan 1, 2015
6.31 INR
Jan 1, 2016
18.77 INR
Jan 1, 2017
19.40 INR
Jan 1, 2023
-152.72 INR
Jan 1, 2024
-24.82 INR
Jan 1, 2025
-51.66 INR
The Hemo Organic P/B history
YEARP/BYoY
-51.66+108.18%
-24.82-83.75%
-152.72-887.24%
19.40+3.34%
18.77+197.34%
6.31+19.32%
5.29—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hemo Organic Stock analysis

What does Hemo Organic do? Hemo Organic Ltd develops chloro chemicals for pharmaceuticals and leather industry applications. The company manufactures ayurvedic and unani pharmaceutical preparations. It produces chemical products, pharmaceuticals, and medical chemicals. The firm's primary customers include pharmaceutical manufacturers and leather industry producers who purchase its chloro chemicals. The company's manufacturing focus on ayurvedic and unani pharmaceuticals targets traditional medicine segments. Hemo Organic Ltd serves the pharmaceutical and leather sectors with its chemical solutions. Hemo Organic Ltd specializes in chloro chemical development for pharmaceutical and leather industry use. The firm's ayurvedic and unani pharmaceutical manufacturing caters to traditional medicine markets. Chemical and medical chemical production supports both pharmaceutical and leather industry needs. The company's products are sold to manufacturers in the pharmaceutical sector and leather processing industry. Its business model centers on supplying chemical solutions to these two industrial segments. Hemo Organic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hemo Organic stock

P/B (Price-to-Book Ratio) of Hemo Organic is -51.66 in 2025.

P/B (Price-to-Book Ratio) of Hemo Organic changed from -24.82 to -51.66, representing a 108.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Hemo Organic since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Hemo Organic with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Hemo Organic

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Hemo Organic